
Conference Coverage
about 1 month ago
Isatuximab OBI Cuts Infusion Reactions: Xavier Leleu, MD, PhDabout 1 month ago
Acalabrutinib-Venetoclax Combos Improve QOL, Safety by Age in CLLabout 1 month ago
Tec-Dara Closes Survival Gap in High-Risk MM: Rahul Banerjee, MDLatest Content

FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis

Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk

Obesity Is Diagnosed Everywhere and Owned Nowhere, Atlanta Clinicians Say

Geographic Barriers Limit Access to Cataract Surgery

Thromboembolic Risk Remains High Across Polycythemia Vera Groups

Shorts










Center on Health Equity & Access
All News

Experts discussed childhood vaccine recommendations, school requirements, exemptions, misinformation, and vaccine hesitancy.

County-level CRC mortality fell substantially since 2000, but some counties still had rates more than 13 times the Healthy People 2030 target in 2019.

A poll finds awareness of the mifepristone abortion pill is rising, but safety doubts and legal battles persist.

Nearly 1 in 3 women aged 21 to 29 and 1 in 7 aged 30 to 65 had never been screened for cervical cancer by 2023.

A narrative review finds insomnia is a consistent, dose-dependent cardiovascular risk factor, but trials have not shown that treatment lowers risk.

A review maps psoriasis's 3-stage path to psoriatic arthritis and tools to catch it before joint damage.

The study authors indicated that future investigations could further facilitate clinical decision-making regarding these regimens’ effectiveness.

AHIP's Jeanette Thornton details health care's prior authorization commitments as a 2027 real-time approval target approaches.

Pulmonary experts detail bronchiectasis care gaps, multidisciplinary strategies, and steps toward Care Center Network designation and standardized care.

The phase 4 study will track serum transthyretin and other biomarkers in 50 adults with ATTR-CM switching from tafamidis to acoramidis over 6 months.






















